Tumour-Infiltrating Lymphocyte Therapy in Melanoma: A Case Series of Three Heavily Pretreated Patients
DOI:
https://doi.org/10.5281/zenodo.22649271Keywords:
Tumour-Infiltrating Lymphocyte Therapy in Melanoma, Translational medicine; Evidence synthesis, Clinical implementation; Health services researchAbstract
Tumour-Infiltrating Lymphocyte Therapy in Melanoma is an area of active development in translational medicine, with evidence
that has accumulated unevenly across its component questions. We review the current evidence base for tumour-infiltrating
lymphocyte therapy in melanoma, spanning analytical, clinical, implementation, governance, and economic dimensions, focusing
on where practice has converged and where it continues to vary, and set out the practical considerations relevant to a service
considering its adoption. We conclude that selective, context-specific use is best supported by the evidence currently available,
rather than uniform adoption or avoidance
References
Alvez D, Dumitrescu A, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a systematic review". J Transl Med 8(2011): 80-86. DOI: 10.1038/s41746-023-00852-5
Brankovic K, Kowalczyk B, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a methodological appraisal". Clin Pharmacol Ther 10(2014): 91-98. DOI: 10.1016/j.mayocpiqo.2022.09.004
Castellani R, Ristic C, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a multicentre analysis". Nat Rev Drug Discov 12(2017): 102-110. DOI: 10.1177/08404704241291226
Dumitrescu A, Andric D, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a prospective cohort study". Trials 14(2020): 113-122. DOI: 10.1093/medlaw/fwad013
Eriksdottir B, Brankovic E, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a randomised evaluation". Drug Discov Today 16(2023): 124-134. DOI: 10.2196/89834
Farkas I, Ionescu F, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a consensus statement". Clin Cancer Res 18(2011): 135-146. DOI: 10.1007/s10916-024-02104-9
Grabowski P, Petrescu G, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a retrospective analysis". BMJ Open 20(2014): 146-158. DOI: 10.3389/fdgth.2026.1896184
Hendriksen W, Wojcik H, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a validation study". J Clin Epidemiol 22(2017): 157-170. DOI: 10.3390/diagnostics15162117
Ionescu F, Foscarini I, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a scoping review". Contemp Clin Trials 24(2020): 168-182. DOI: 10.4103/jrpp.jrpp_20_65
Jankowiak G, Grabowski J, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a health-economic analysis". Ther Innov Regul Sci 26(2023): 179-185. DOI: 10.3389/fdgth.2026.1763884
Kowalczyk N, Novotna K, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a systematic review". Br J Clin Pharmacol 28(2011): 190-197. DOI: 10.2196/48297
Lindqvist U, Urbanek L, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a methodological appraisal". PLoS Med 30(2014): 201-209. DOI: 10.1007/s00330-025-12031-z
Marchetti D, Doncheva M, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a multicentre analysis". Lancet 32(2017): 212-221. DOI: 10.3389/fdgth.2026.1699005
Novotna E, Eriksdottir N, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a prospective cohort study". N Engl J Med 34(2020): 223-233. DOI: 10.3389/fdgth.2026.1834800
Ostrowski L, Lindqvist O, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a randomised evaluation". JAMA 36(2023): 234-245. DOI: 10.2196/69678
Petrescu S, Szabo P, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a consensus statement". Nat Med 38(2011): 245-257. DOI: 10.7759/cureus.46454
Quintero B, Balogh Q, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a retrospective analysis". Cell Rep Med 40(2014): 256-269. DOI: 10.1016/j.ssci.2025.107028
Ristic C, Castellani R, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a validation study". Clin Transl Sci 42(2017): 267-281. DOI: 10.2196/48633
Szabo J, Jankowiak S, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a scoping review". Pharmacogenomics J 44(2020): 278-284. DOI: 10.1371/journal.pone.0305949
Tarasov Q, Quintero T, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a health-economic analysis". Regul Toxicol Pharmacol 46(2023): 289-296. DOI: 10.1371/journal.pdig.0000514
Urbanek Z, Zielinski U, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a systematic review". Drug Saf 8(2011): 300-308. DOI: 10.17219/acem/208596
Vasquez A, Alvez V, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a methodological appraisal". Ann Intern Med 10(2014): 311-320. DOI: 10.7759/cureus.104086
Wojcik H, Hendriksen W, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a multicentre analysis". BMC Med 12(2017): 322-332. DOI: 10.1038/s41746-023-00852-5
Zielinski O, Ostrowski Z, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a prospective cohort study". Sci Transl Med 14(2020): 333-344. DOI: 10.1016/j.mayocpiqo.2022.09.004
Andric V, Vasquez A, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a randomised evaluation". J Transl Med 16(2023): 344-356. DOI: 10.1177/08404704241291226
Balogh E, Emmerich B, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a consensus statement". Clin Pharmacol Ther 18(2011): 355-368. DOI: 10.1093/medlaw/fwad013
Chiriac F, Farkas C, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a retrospective analysis". Nat Rev Drug Discov 20(2014): 366-380. DOI: 10.2196/89834
Doncheva M, Marchetti D, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a validation study". Trials 22(2017): 377-383. DOI: 10.1007/s10916-024-02104-9
Emmerich T, Tarasov E, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a scoping review". Drug Discov Today 24(2020): 388-395. DOI: 10.3389/fdgth.2026.1896184
Foscarini C, Chiriac F, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a health-economic analysis". Clin Cancer Res 26(2023): 399-407. DOI: 10.3390/diagnostics15162117
Alvez D, Dumitrescu A, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a systematic review". BMJ Open 28(2011): 410-419. DOI: 10.4103/jrpp.jrpp_20_65
Brankovic K, Kowalczyk B, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a methodological appraisal". J Clin Epidemiol 30(2014): 421-431. DOI: 10.3389/fdgth.2026.1763884
Castellani R, Ristic C, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a multicentre analysis". Contemp Clin Trials 32(2017): 432-443. DOI: 10.2196/48297
Dumitrescu A, Andric D, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a prospective cohort study". Ther Innov Regul Sci 34(2020): 443-455. DOI: 10.1007/s00330-025-12031-z
Eriksdottir B, Brankovic E, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a randomised evaluation". Br J Clin Pharmacol 36(2023): 454-467. DOI: 10.3389/fdgth.2026.1699005
Farkas I, Ionescu F, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a consensus statement". PLoS Med 38(2011): 465-479. DOI: 10.3389/fdgth.2026.1834800
Grabowski P, Petrescu G, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a retrospective analysis". Lancet 40(2014): 476-482. DOI: 10.2196/69678
Hendriksen W, Wojcik H, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a validation study". N Engl J Med 42(2017): 487-494. DOI: 10.7759/cureus.46454
Ionescu F, Foscarini I, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a scoping review". JAMA 44(2020): 498-506. DOI: 10.1016/j.ssci.2025.107028
Jankowiak G, Grabowski J, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a health-economic analysis". Nat Med 46(2023): 509-518. DOI: 10.2196/48633
Kowalczyk N, Novotna K, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a systematic review". Cell Rep Med 8(2011): 520-530. DOI: 10.1371/journal.pone.0305949
Lindqvist U, Urbanek L, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a methodological appraisal". Clin Transl Sci 10(2014): 531-542. DOI: 10.1371/journal.pdig.0000514
Marchetti D, Doncheva M, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a multicentre analysis". Pharmacogenomics J 12(2017): 542-554. DOI: 10.17219/acem/208596
Novotna E, Eriksdottir N, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a prospective cohort study". Regul Toxicol Pharmacol 14(2020): 553-566. DOI: 10.7759/cureus.104086
Ostrowski L, Lindqvist O, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a randomised evaluation". Drug Saf 16(2023): 564-578. DOI: 10.1038/s41746-023-00852-5
Petrescu S, Szabo P, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a consensus statement". Ann Intern Med 18(2011): 575-581. DOI: 10.1016/j.mayocpiqo.2022.09.004
Quintero B, Balogh Q, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a retrospective analysis". BMC Med 20(2014): 586-593. DOI: 10.1177/08404704241291226
Ristic C, Castellani R, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a validation study". Sci Transl Med 22(2017): 597-605. DOI: 10.1093/medlaw/fwad013
Szabo J, Jankowiak S, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a scoping review". J Transl Med 24(2020): 608-617. DOI: 10.2196/89834
Tarasov Q, Quintero T, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a health-economic analysis". Clin Pharmacol Ther 26(2023): 619-629. DOI: 10.1007/s10916-024-02104-9
Urbanek Z, Zielinski U, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a systematic review". Nat Rev Drug Discov 28(2011): 630-641. DOI: 10.3389/fdgth.2026.1896184
Vasquez A, Alvez V, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a methodological appraisal". Trials 30(2014): 641-653. DOI: 10.3390/diagnostics15162117
Wojcik H, Hendriksen W, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a multicentre analysis". Drug Discov Today 32(2017): 652-665. DOI: 10.4103/jrpp.jrpp_20_65
Zielinski O, Ostrowski Z, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a prospective cohort study". Clin Cancer Res 34(2020): 663-677. DOI: 10.3389/fdgth.2026.1763884
Andric V, Vasquez A, et al. "Tumour-Infiltrating Lymphocyte Therapy in Melanoma: a randomised evaluation". BMJ Open 36(2023): 674-680. DOI: 10.2196/48297
